Huntsman Cancer Institute, University of Utah
Salt Lake City, Utah, United States
Dr. Howard Colman is a Professor (Tenured) in the Depts. of Neurosurgery, Neurology, and Internal Medicine (Oncology). He is Co-Leader of the Experimental Therapeutics CCSG program and theeCenter for Neurologic Cancers at HCI. Dr. Colman received his M.D. and a Ph.D. in Neuroscience from Washington University School of Medicine in St. Louis, Missouri. He completed a Neuro-Oncology fellowship at the UT MD Anderson Cancer Center in Houston, Texas and is board-certified in Neurology and Neuro-Oncology. Dr. Colman divides his time between patient care and clinical and laboratory research. Dr. Colman's clinical interests are treatment of primary and metastatic brain tumors and diagnosis and management of neurologic complications of cancer. His clinical research is focused on developing and testing new therapies for brain tumors. His laboratory interests are identification of molecular markers of prognosis and treatment response in brain tumors, and the role of tumor stem cells in the development and treatment of resistance of brain tumors. Dr. Colman has been PI and co-investigator on multiple brain tumor clinical trials and grants. He has served as PI, Co-I, or Project Leader on multiple NCI and NIH funded grants and clinical trials. He is the former Medical Director of Neuro-Oncology at Intermountain Medical Center, and former Acting Chair of Hematology and Oncology at the Salt Lake City VA Hospital. He is a member and/or served on various committees for of the American Society of Clinical Oncology, the Society for Neuro-Oncology, and the American Association for Cancer Research, the College of American Pathologists, and the American Joint Committee on Cancer. Dr. Colman has published more than 150 peer-reviewed journal articles, as well as numerous book chapters, and abstracts.
